Smarter Science, Healthier Lives, AI for A- Hepatitis Free Future
Keywords:
Artificial intelligence (AI), viral hepatitis, machine learning, Drug discovery, Medical imaging, Liver diseases, Disease prediction, Healthcare, Personalized medicine.Abstract
Artificial intelligence (AI) has emerged as a transformative technology in modern healthcare, offering innovative solutions for the prevention, diagnosis, treatment, and management of liver diseases, particularly viral hepatitis. With over 90% accuracy in diagnosing diseases from medical images, artificial intelligence (AI) is reshaping the healthcare landscape, transforming medical imaging, diagnosis, drug discovery, patient care, and more. AI-driven approaches, including machine learning, deep learning, and advanced data analytics, enable the rapid analysis of complex clinical, imaging, pathological, and genomic data, thereby improving diagnostic accuracy, predicting disease progression, and supporting clinical decision-making. In drug discovery, AI accelerates target identification, virtual screening, lead optimization, and drug repurposing, significantly reducing the time and cost associated with conventional pharmaceutical development. As AI technologies continue to evolve, they have the potential to revolutionize hepatitis prevention and management, ultimately improving patient outcomes and supporting the global goal of eliminating viral hepatitis as a public health threat.
